Introduction {#s1}
============

Human aging is associated with a reduction in muscle mass and strength that can lead to functional impairment in activities of daily living. Sarcopenia refers to a reduction in fat free mass (FFM, \>2 SD below normal) that can occur with aging and this leads to functional impairments in up to 25% of women and men over the age of 75 y [@pone.0000991-Castillo1]--[@pone.0000991-Lau1]. Resistance exercise training is an important countermeasure for sarcopenia with numerous studies demonstrating improvements in strength, function, and fat free mass in older adults [@pone.0000991-Charette1]--[@pone.0000991-Borst1]. Several strategies have been evaluated to augment the gains in FFM and strength during the course of resistance exercise training including sex hormone administration [@pone.0000991-Lambert1] and nutritional supplements [@pone.0000991-Fiatarone1]. While there is no question that resistance exercise is the most potent stimulus for the promotion of strength and FFM gains, adjunctive strategies to augment these effects may enhance the overall efficacy of strength training interventions. An increase in body fat occurs with the aging process. This increase in percentage body fat compounds the negative effects of the accompanying sarcopenia [@pone.0000991-Newman1].

Creatine monohydrate (CrM) is a guanidino compound that is produced endogenously and is naturally occurring in meat containing products. In addition to its role as a temporal and spatial energy buffer, CrM supplementation can enhance increases in fat-free mass (FFM) when given in association with a several month resistance exercise training program [@pone.0000991-Kreider1]--[@pone.0000991-Brose1]. There are several effects of CrM administration that may enhance resistance exercise-induced strength gains including activation of myogenic determination factors [@pone.0000991-Hespel1], enhancement of satellite cell activation and recruitment [@pone.0000991-Olsen1]--[@pone.0000991-Dangott1], reduction of amino acid oxidation and protein breakdown [@pone.0000991-Parise1], and an increase in myofibrillar mRNA and protein content [@pone.0000991-Willoughby1]. Our group [@pone.0000991-Brose1], and others [@pone.0000991-Chrusch1], have found that CrM supplementation during a resistance exercise training program increased FFM gains and some measures of strength in older adults. By contrast, a few other groups have not confirmed such results [@pone.0000991-Bermon1], [@pone.0000991-Eijnde1]. However, in one case there was no increase in strength following one year of low intensity resistance exercise training [@pone.0000991-Eijnde1], and the other study was cross-sectional in design [@pone.0000991-Bermon1]. Given some discrepancy in the literature, one aim of the current study was to evaluate the efficacy of CrM supplementation as an adjunct to six months of moderate intensity resistance exercise training on measures of body composition, functional tasks, and strength in a cohort of older adult men and women. Given that body fat mass gain is another feature of aging, and this was not affected by resistance training, with or without creatine, in our last study [@pone.0000991-Brose1], we also wanted to evaluate whether other nutritional compounds could enhance body fat mass losses.

Conjugated linoleic acid (CLA) refers to two naturally occurring isomers of linoleic acid which are found predominately in dairy products and plant oils such as flax seed [@pone.0000991-Tricon1], [@pone.0000991-Belury1]. Studies in animals have found a reduction in intra-abdominal fat and enhanced FFM gains with CLA supplementation [@pone.0000991-Tricon1], [@pone.0000991-Wendel1]--[@pone.0000991-Sebedio1]. Other work has reported that CLA-mediated whole body fat loss in overweight men and women [@pone.0000991-Gaullier1]--[@pone.0000991-Gaullier2]; however, the efficacy of CLA in combination with resistance exercise training in normal weight young men is equivocal [@pone.0000991-Kreider2]. There have been some concerns that CLA can promote oxidative stress (8-isoprostanes, 8-isoP) [@pone.0000991-Riserus1], [@pone.0000991-Basu1], and induce hepatic lipid accumulation [@pone.0000991-Kelley1]. The latter effect appears to be isomer specific and is not seen with commercially available mixtures containing equal proportions of each of the two major isomers [@pone.0000991-Wendel1], [@pone.0000991-Kim1]. Therefore, a second aim of the study was to determine whether CLA leads to a reduction in body fat during resistance exercise training and to evaluate safety issues related to oxidative stress and hepatic dysfunction in older adults.

In addition to the biomechanical disadvantage resulting from obesity, body fat accumulation is associated with negative health outcome indicators including an increase in markers of inflammation, oxidative stress, glucose dysregulation, and dyslipidemia [@pone.0000991-Singh1]. The influence of resistance exercise training on markers of inflammation, blood lipids, and adipokines has rarely been studied in older adults [@pone.0000991-Fatouros1]. Consequently, the final aim of the study was to evaluate whether resistance exercise training with or without a CrM+CLA supplementation would favorably alter markers of inflammation, oxidative stress, blood lipids or adipokines in older adults.

Materials and Methods {#s2}
=====================

Participants {#s2a}
------------

Thirty-nine community dwelling, older adult (65--85 y), men (n = 19) and women (n = 20) were recruited from within a 30 km radius of our research centre (McMaster University) to participate in a six month resistance exercise training study. None of the subjects participated in sports training programs or performed vigorous physical activity more than 3 times per wk, \>30 min/d, in the year prior to the commencement of the study. None of the subjects had participated in resistance exercise activities in the preceding two years and most had not done such training. No participants required the use of assistive devices for mobility. Recruitment strategies included local newspaper ads, radio announcements, and flyers distributed to surrounding areas. Each subject underwent a thorough screening, which included a telephone interview and a medical evaluation. Exclusion criteria included: evidence of coronary heart disease; congestive heart disease; uncontrolled hypertension; chronic obstructive pulmonary disease; diabetes mellitus; renal failure; major orthopedic disability; and smoking. All the women were post-menopausal and were not taking hormone replacement therapy. The study was approved by the Hamilton Health Sciences Research Ethics Board and the study has been registered in ClinicalTrials.gov under \# NCT00473902. The protocol for this trial is available as supporting information; see [Protocol S1](#pone.0000991.s001){ref-type="supplementary-material"}. Information sessions were conducted to inform the subjects of the risks and benefits of participating in a resistance exercise training program and they provided written consent.

After the initial screening, the subjects were required to perform a cycle ergometry test to 5 METS (metabolic equivalents) on a mechanically braked cycle ergometer (Monarch, Varberg, Sweden). A 12-lead electrocardiogram (ECG, Burdick, Kone Instruments Corp., Espoo, Finland) was taken prior to and upon completion of the ergometry test, as part of exclusion criteria to participate in the resistance exercise training program. Any participants with abnormal resting ECG\'s or a blood pressure of \>160 mmHg systolic and/or 95 mmHg diastolic were not allowed to complete the screening tests. One subject with questionable post-exercise exercise ECG changes was referred to a cardiologist for assessment and was cleared to participate in the study. A summary of the recruitment strategy and allocation is presented in [Figure 1](#pone-0000991-g001){ref-type="fig"}.

![Summary of the recruitment strategy and allocation.](pone.0000991.g001){#pone-0000991-g001}

Nutritional Supplementation {#s2b}
---------------------------

After completion of pre-training testing, subjects were then randomized to either a combination of CrM and CLA (CrM+CLA) (5 g CrM (Neotine®)+2 g dextrose/d, Palo Alta, CA); and 6 g of CLA (CLA-ONE® 45% c9, t11; 45% t10, c12, Pharmanutrients, Gurnee, IL) or placebo (PL) (7 g dextrose/d+6 g of safflower oil/d) for 24 weeks. The CrM+CLA group consisted of 11 men and 10 women, while the PL group consisted of 8 men and 10 women ([Table 1](#pone-0000991-t001){ref-type="table"}). Randomization was done by having recruited men and women randomly draw from two blocks (one male and one female) each containing twenty-four shuffled/sealed envelopes with each block having equal allocation to treatment (N = 12/block) or placebo (N = 12/block). After six months of recruitment and a lack of drop-outs, we closed recruitment with a total of 19 men and 20 women randomized to the trial. The flavor and appearance of the supplements were indistinguishable by the subjects and investigators. Subjects were instructed to consume their supplements daily and return unused supplements every month to ensure compliance.

10.1371/journal.pone.0000991.t001

###### Subject Characteristics, Body Composition and Bone Density.

![](pone.0000991.t001){#pone-0000991-t001-1}

                  Placebo                   Supplement                                                                                                                                                                                                        
  ------------- ----------- ------------------------------------------- ----------- ----------- ----------- -------------------------------------------------------------------------------- ----------- ------------------------------------------- -------- --------
  Age (y)        74.8±6.6                       NC                       68.3±4.4       NC       71.8±5.2                                          NC                                         69.5±3.8                       NC                         NC      0.01
  Height (cm)    172.1±7.4                      NC                       160.8±6.8      NC       171.0±7.4                                         NC                                         161.1±5.2                      NC                         NC      0.00
  Weight (kg)    76.7±8.2                    77.2±7.8                    65.3±10.5   65.1±10.2    81.6±11                                      81.8±11.6                                      66.2±8.4                     65.7±8                      0.98    0.0002
  FFM (kg)       55.8±5.5    57.2±5.7[†](#nt103){ref-type="table-fn"}    41.1±5.1    41.5±5.1    58.1±8.6    60.8±8.5[\*](#nt102){ref-type="table-fn"} ^,^ [†](#nt103){ref-type="table-fn"}   41.3±4.4    42.9±4.7[\*](#nt102){ref-type="table-fn"}   0.0001   0.0001
  FM (kg)        18.8±4.4                    18.2±4.2                    22.8±5.7    22.6±5.9    21.4±4.9                      19.9±5.9[\*](#nt102){ref-type="table-fn"}                      23.5±5.3    21.5±5.6[\*](#nt102){ref-type="table-fn"}   0.0001    0.08
  B.M.I.         25.9±2.7                    26.1±2.5                    25.2±3.0    25.1±2.9    27.8±2.1                                       27.8±2.1                                      25.5±3.1                    25.3±3.0                     0.07     0.86
  BMD-total      1.21±0.09                   1.25±0.11                   1.13±0.12   1.15±0.13   1.20±0.13                                     1.23±0.13                                      1.02±0.09                   1.04±0.08                    0.34    0.0005
  BMD-hip        1.01±0.09   0.98±0.08[†](#nt103){ref-type="table-fn"}   0.86±0.14   0.84±0.13   0.94±0.10                     0.92±0.10[†](#nt103){ref-type="table-fn"}                      0.83±0.10                   0.81±0.11                   0.0001   0.001
  BMD-L-spine    1.12±0.06                   1.12±0.07                   1.12±0.15   1.11±0.18   1.19±0.14                                     1.19±0.15                                      0.94±0.11                   0.94±0.09                    0.66    0.004

Values are means±standard deviation. NC = no change; FFM = fat free mass; FM = fat mass; BMI = body mass index.

indicates a significant interaction between training and supplement (see text).

indicates a significant interaction between men and women in response to training (see text).

Strength Training {#s2c}
-----------------

Subjects followed a resistance exercise training program twice per week for six months, while being supervised in a group environment for each training session. All participants recorded each contraction in a log book. Sessions were held on Mondays and Wednesdays (1200 h--1400 h) or Tuesdays and Thursdays (1900 h--2100 h) for 24 weeks. Each training session was preceded by a 5-min aerobic warm-up of spinning on a cycle ergometer or brisk walking, followed by a brief stretching session. Twelve exercises were used to train the major muscle groups of the upper and lower body in a circuit-set system using weight training machines (Universal Gym Equipment Inc., Cedar Rapids, Iowa). Subjects performed 12 repetitions of each exercise including; leg press, chest press, leg extension, leg flexion, shoulder press, lat pull-down seated row, calf raise, abdominal crunch, and back extension and 10 repetitions for arm flexion and arm extension. The training protocol progressed from performing 1 set of each exercise at 50% of their 1RM (repetition maximum) values up to 3 sets of 75% of their 1RM values over the course of the training period. The 1RM\'s were re-tested every 4 weeks to accommodate any increases in strength by the subjects and re-adjusted to the new 1RM value.

Testing {#s2d}
-------

Once recruited, each subject was put through three separate visits for pre- and post-testing. Testing included analyses of functional and strength measures, body composition, diet records and urine and blood collection (see below). The same individual completed all of the strength testing and DEXA scanning to ensure operative consistency.

Functional Testing {#s2e}
------------------

A total of five functional tasks were performed once using a stopwatch that recorded times to an accuracy 1/100 of a second. These tasks included; 1. 30 metre walking-subjects walked as fast and safely as possible for a 30m distance that was marked off with clear start and stop points; 2. Balance-subjects were timed during a 'heel to toe' tandem gait on a pre-marked 9.14-meter tape line on the floor. Subjects could keep their arms out to aid in balance and for safety. Any step off the line resulted in a one second addition to the total task time; 3. Sit to stand-subjects performed a series of consecutive rising and sitting from a sturdy, armless plastic chair secured against a wall. Starting from a seated position, the numbers of completed repetitions were recorded over 30 s, with their arms at their sides or across their chests while performing the task; 4. Chair rise and walk--starting from a seated position, subjects stood up and walked as quickly as possible in a predetermined straight line to a pylon 9.14 m, go around the pylon, and return to their original seated position; 5. Stair climb--subjects climbed two flights of stairs (N = 14), starting with both feet on the bottom platform and ascending one step at a time, using a handrail only if insecure.

Strength testing {#s2f}
----------------

### Isometric ankle dorsiflexion {#s2f1}

Maximal ankle dorsiflexion was taken as the highest of three trials of 5 s maximal contractions using a custom-made isometric device with the ankle joint at 90°, as previously described [@pone.0000991-Tarnopolsky2].

### Hand grip strength {#s2f2}

Hand grip strength was measured using an isometric dynamometer (JAMAR®, Sammons, Bolingbrook, IL). The grip width was adjusted to hand size and subjects performed three×5 s with a one min rest between each trial.

### Isometric and isokinetic knee extension {#s2f3}

Isometric and isokinetic (120°/sec) knee extension was measured by using a dynamometer (Biodex System 3, Biodex Medical Systems, Shirley, NY). Subjects were positioned into the machine with the knee flexed at 90° and performed three×5 s maximal voluntary contractions with 30 s rest between each trial at each speed.

### 1RM and endurance testing {#s2f4}

One repetition maximum (1 RM) testing occurred prior to training commencement and post-training for use as an outcome measurement and to set individual weight assignments for the training sessions (as above). Subjects were tested for training intensity adjustments for all 12 exercises described above, and for outcome variables using four machines: leg press, chest press, arm flexion, and leg extension (Universal Gym Equipment Inc., Cedar Rapids, Iowa). Muscle endurance was also completed at the end of the study using the weight from the initial 1RM by determining the number of repetitions done post-training using the original 1RM weight.

Body composition assessment {#s2g}
---------------------------

Body mass and height were measured to the nearest 0.1 kg and 0.5 cm, respectively, using a calibrated electronic scale (Health-O-meter Pro Series Electronic Scale, Bridgeview, IL) ([Table 1](#pone-0000991-t001){ref-type="table"}). Body composition was assessed using dual energy x-ray absorptiometry (DEXA) scan (Hologic QDR 1000W, Waltham, MA) and a software program for adults (Hologic, V.8.26a). Fat free mass (FFM), fat mass (FM) and bone mineral density (BMD) of the entire body, spine, and femur were recorded.

Diet records {#s2h}
------------

To determine dietary composition and consistency during the study, two prospective 3d diet records were collected from the subjects 1 wk prior to the start and during the final week of exercise training. Dietary intake was analyzed using computerized diet analysis software (Diet Analysis Plus Version 7.0, Thompson Wadsworth, Canada) for the determination of total energy, % protein (PRO), carbohydrate (CHO), and fat, alcohol, and calcium intake.

Urine and blood collections {#s2i}
---------------------------

Twenty-four hour urine samples were collected into 4 L containers before training began, and once again in last week of training. The samples were kept at 4°C, and delivered to the laboratory within 24 h where the volume was measured and samples were aliquoted into 5 mL polyethylene tubes and stored at −80°C until subsequent analysis (see below). All subjects arrived between 0800 h and 0930 h in an overnight post-absorptive state. Blood was taken from the antecubital vein and drawn into 10 mL evacuated tubes with heparin used for plasma collection and non-treated tubes were used to collect serum Samples were centrifuged at 1200 rpm for 10 min and the serum was aliquoted into 1.5 mL polyethylene microcentrifuge tubes and stored at −80°C for subsequent analysis.

Blood and Urine Analyses {#s2j}
------------------------

Serum glucose, creatine kinase (CK), bilirubin, gamma glutamyl transferase (GGT), low density lipoprotein (LDL), high density lipoprotein (HDL), and total cholesterol were each analyzed by the core laboratory at Hamilton Health Sciences Centre in batches containing samples from men and women, pre-post training, and from each of the treatment groups. All other metabolites were analyzed according to the manufacturer\'s guidelines using ELISA-based assays for leptin (R&D Systems, DLP00, Minneapolis, MN), C-reactive protein (CRP) (Alpha Diagnostic, U54401841, San Antonio, TX), adiponectin (R&D Systems, DY1065, Minneapolis, MN), and interleukin-6 (I-L6) (R&D Systems, HS600B, Minneapolis, MN). Insulin concentration was determined using a commercially available radio-immunoassay (Coat-A-Count, TK1N2, Diagnostics Products, Los Angeles, CA). The HOMA-IR index was calculated using the equation (\[fasting serum insulin (uU/mL)×fasting plasma glucose (mmol/L)\]/22.5).

Urine creatine (Cr) and creatinine (Crn) were analyzed using high-performance liquid chromatography as described previously by our group[@pone.0000991-Rodriguez1]. The creatinine clearance rate was calculated from the measured serum and urinary creatinine values using the equation (urine creatinine (mg/dL)×urine vol. (mL/24 h)/\[1440×serum creatinine (mg/dL)\]). Urinary 8-isoprostanes (8-isoP, Cayman Chemical, \# 516351, Ann Arbour, MI Cayman Chemical, \# 516351, Ann Arbour, MI), 8-hydroxy-2-deoxy-guanosine (8-OH-2dG, KOG-200SE, Baltimore, MD), and *N*-telopeptides (Osteomark, NTx \# 504837, Princeton, NJ) were analyzed by ELISA according to manufacturer\'s instructions.

Statistical Analysis {#s2k}
--------------------

The subject characteristics were analyzed using an unpaired t-test (age and height). In accordance with NIH guidelines, and given that sex differences in sarcopenia have been reported [@pone.0000991-Castillo1]--[@pone.0000991-Lau1], we planned our statistical analysis to determine whether or not sex differences existed. For the main outcome variables of body composition (FFM and body fat) and strength (knee extension and handgrip) we first ran a Kolmogorov-Smirnov test and reviewed the distribution plots to determine whether the data was normally distributed. In all of these cases the criteria for a normal distribution were met and our outcome variables were analyzed using a three-way analysis of variance (ANOVA) with sex as a between variable (men vs. women), and training (pre vs. post) and supplement (CrM+CLA vs. placebo) as the repeated measures variable. A Tukey\'s HSD *post-hoc* analysis for unequal sample sizes was used to locate pair-wise differences when statistical significance was observed. In addition, body composition measures were further analyzed to blood and urine markers using Pearson R correlation. Significance was set at P≤0.05 (two-tailed). All data was analyzed using a computerized program (Statistica V5, Statsoft, Tulsa, OK). Values are reported as mean±standard deviation (SD).

Results {#s3}
=======

Subject Characteristics and Body Composition {#s3a}
--------------------------------------------

The men were slightly older, taller, heavier, and had higher FFM compared to the women ([Table 1](#pone-0000991-t001){ref-type="table"}). Resistance exercise training increased FFM more for men (+2.0 kg, P\<0.001) compared to women (+1.0 kg, P\<0.05), with a significantly greater increase in FFM for the CrM+CLA group (+2.1 kg, P = 0.02) compared to placebo (+0.9 kg, P = 0.06, NS) ([Table 1](#pone-0000991-t001){ref-type="table"}, [Figure 2](#pone-0000991-g002){ref-type="fig"}). There was a significantly greater reduction in fat mass in the CrM+CLA group following training (−1.9 kg, P\<0.001) as compared to placebo (−0.4 kg, NS)([Table 1](#pone-0000991-t001){ref-type="table"}, [Figure 2](#pone-0000991-g002){ref-type="fig"}). Total bone mineral density (BMD) was lower for women and did not change after training. Hip BMD was lower for women and decreased slightly, but significantly for men only after training (interaction, P\<0.05). Lumbar BMD was lower for women but did not change in response to exercise training with or without CrM+CLA ([Table 1](#pone-0000991-t001){ref-type="table"}).

![(A) Changes in fat free mass between supplement groups and sex in response to training.\
(B) Changes in fat mass between supplement and sex in response to training. Values are means±standard deviation. \*-indicates a significant difference with a p\<0.05 (see text).](pone.0000991.g002){#pone-0000991-g002}

Diet Analysis {#s3b}
-------------

Men consumed more energy compared to women (P\<0.02), but there was no effect of training on energy intake, and men on placebo had lower % fat intake vs. all other groups. There were no other sex, training, or supplement effects on dietary composition ([Table 2](#pone-0000991-t002){ref-type="table"}).

10.1371/journal.pone.0000991.t002

###### Dietary Analysis.

![](pone.0000991.t002){#pone-0000991-t002-2}

                     Placebo    Supplement                                                                             
  ----------------- ---------- ------------ ---------- ---------- ----------- ----------- ---------- ---------- ------ -------
  Intake (kcal/d)    2812±914    2777±689    1989±178   1886±356   2435±1108   2409±1110   1916±466   1974±681   0.81   0.02
  \% PRO               16±3        16±2        16±3       17±3       15±3        16±3        17±4       17±2     0.67   0.26
  \% CHO               60±4       61±10       49±10      52±11       50±6        48±5       49±10       51±6     0.48   0.14
  \% FAT               26±4        23±4        35±8       33±5       34±6        34±4        35±6       34±4     0.18   0.007
  PRO (g/kg)/d       1.3±0.6     1.4±0.3     1.4±0.4    1.2±0.3     1.1±0.4     1.1±0.3    1.2±0.2    1.3±0.3    0.81   0.93
  \% C~2~H~5~OH      3.7±3.3     6.1±2.4     3.2±2.9    3.3±4.1     4.1±4.6      5.1±4     3.8±3.7    3.1±3.4    0.21   0.27
  Ca^++^             1204±387    1162±368    718±209    758±158     913±413     773±335    987±462    951±409    0.52   0.17

Values are means±standard deviation. PRO = protein; CHO = carbohydrate; C~2~H~5~OH = ethanol; Ca^++^ = calcium.

Muscle Strength Testing {#s3c}
-----------------------

All measures of strength were higher for men compared to women ([Table 3](#pone-0000991-t003){ref-type="table"}). Every measure of muscle strength (P\<0.05 to P\<0.001) increased following exercise training ([Table 4](#pone-0000991-t004){ref-type="table"}). The CrM+CLA supplement did not further enhance isometric strength measurements after training; however, isokinetic strength increased more after training for those on supplement vs. placebo (P\<0.05). Women on CrM+CLA showed a greater increase in knee extension 1RM strength after training as compared to all other groups (P\<0.05). Muscle endurance increased significantly (P\<0.0001) following training (\# reps. post-training @ pre-training 1RM) with the improvements in chest press and arm flexion showing a greater improvement (P\<0.05), with a trend towards a greater improvement in leg press (P = 0.077), for the CrM+CLA group. There was a three-way interaction (P\<0.05) with women showing a greater improvement in knee extension endurance after training for the CrM+CLA group ([Table 3](#pone-0000991-t003){ref-type="table"}). Correlation analysis showed that those with the lowest initial knee extension strength had the greatest percentage increase in strength after training (r = −0.61, r^2^ = 0.37, P\<0.05).

10.1371/journal.pone.0000991.t003

###### Muscle Strength Tests.

![](pone.0000991.t003){#pone-0000991-t003-3}

                                Placebo     Supplement                                                                                                                                                        
  --------------------------- ------------ ------------ ----------- ----------- ------------ --------------------------------------------- ----------- --------------------------------------------- -------- --------
  Isometric                                                                                                                                                                                                   
  Knee Ext.(Nm)                133.9±37.3   152.0±44.7   78.6±12.6   96.0±20.2   135.8±37.4                   151.4±52.4                    86.0±14.3                   105.6±17.8                    0.0001   0.0001
  Dorsiflexion(Nm)             56.7±14.9    55.9±14.4    35.5±4.6    37.3±5.2    48.8±10.9                     54.7±12.7                    30.4±5.2                     34.1±7.6                      0.03    0.0001
  Jamar (kg)                      39±6         42±6        25±4        27±4         39±7                         43±7                         27±5                         30±4                       0.0001   0.0001
  Isokinetic                                                                                                                                                                                                  
  Knee 120 deg/sec             93.1±26.7    101.3±23.4   53.2±20.2   64.7±9.2    88.2±27.2    108.2±26.2[\*](#nt106){ref-type="table-fn"}   57.7±16.4   68.0±15. 5[\*](#nt106){ref-type="table-fn"}   0.0001   0.0001
  1 Repetition Maximum (lb)                                                                                                                                                                                   
  Chest Press                    98±23        136±16       60±12       91±9        104±35                       146±38                        53±7                         89±15                      0.0001   0.0001
  Arm Flexion                    64±17        104±23       32±9        57±11       76±35                        115±36                        29±7                         61±16                      0.0001   0.0001
  Leg Press                      205±55       269±52      137±33      187±54       215±59                       295±74                       123±22                       200±31                      0.0002   0.0001
  Knee Extension                 106±20       158±31       81±27      109±13       117±39                       163±44                        64±16       113±18[‡](#nt107){ref-type="table-fn"}      0.0001   0.0001
  Endurance (lb)                                                                                                                                                                                              
  Chest Press                     1±0         17±11         1±0        18±6         1±0         22±10[\*](#nt106){ref-type="table-fn"}         1±0        32±11[\*](#nt106){ref-type="table-fn"}      0.0001    0.12
  Arm Flexion                     1±0          16±7         1±0        15±9         1±0         21±12[\*](#nt106){ref-type="table-fn"}         1±0         25±9[\*](#nt106){ref-type="table-fn"}      0.0001    0.56
  Leg Press                       1±0         21±16         1±0        27±12        1±0                          27±13                         1±0                         46±27                      0.0001    0.07
  Knee Extension                  1±0          17±8         1±0        10±2         1±0                          14±4                          1±0         17±6[‡](#nt107){ref-type="table-fn"}       0.0001    0.38

Values are means±standard deviation. RM = repetition maximum.

indicates a significant interaction between training and supplement (see text).

indicates a significant interaction between training, supplement and gender (see text).

10.1371/journal.pone.0000991.t004

###### Functional Tests.

![](pone.0000991.t004){#pone-0000991-t004-4}

                          Placebo    Supplement                                                                              
  ---------------------- ---------- ------------ ---------- ---------- ----------- ---------- ---------- ---------- -------- --------
  Sit and Stand (\#)        13±2        16±1        10±2       14±4       12±2        15±3       11±3       13±2     0.0001   0.0005
  Timed Stairs (sec)      6.8±0.6     6.9±1.5     8.7±1.7    8.1±1.6     8.1±1.3    7.7±1.5    7.8±0.9    6.9±0.9    0.004     0.24
  Walk Test (sec)         14.8±2.7    13.7±2.1    17.5±2.5   16.1±2.4   17.3±2.6    16.6±3.5   16.8±2.0   15.1±1.2   0.0001    0.34
  Chair and Walk (sec)    13.4±1.7    11.4±2.3    15.0±2.4   13.3±2.2   14.5±2.4    13.7±3.1   14.3±2.1   12.6±1.3   0.0001    0.08
  Balance Walk (sec)      23.4±8.5    22.3±9.0     33±6.1    28.1±7.6   32.6±11.4   27.4±8.1    31.9±8    25.3±7.8    0.04     0.04

Values are means±standard deviation. Sec = seconds; \# = number completed.

Functional Tests {#s3d}
----------------

Women had slightly worse balance walk scores and sit to stand performance compared to men ([Table 4](#pone-0000991-t004){ref-type="table"}). Exercise training improved all five measures of functional capacity for men and women with no differential effect of CrM+CLA ([Table 4](#pone-0000991-t004){ref-type="table"}).

Blood Analyses {#s3e}
--------------

There were a number of sex differences in the blood measurements with higher leptin, adiponectin, and HDL-C concentrations in women (P\<0.001). Furthermore, women had lower creatinine and bilirubin concentrations as compared with men. Following resistance exercise training, there was an increase in CK activity, and an increase in total and LDL cholesterol (P\<0.05), without a change in LDL/HDL ratio ([Table 5](#pone-0000991-t005){ref-type="table"}). As expected[@pone.0000991-Brose1], an increase in serum creatinine was seen following training only in the CrM+CLA group (P\<0.05) ([Table 5](#pone-0000991-t005){ref-type="table"}).

10.1371/journal.pone.0000991.t005

###### Blood Analysis.

![](pone.0000991.t005){#pone-0000991-t005-5}

                       Placebo    Supplement                                                                                                                                                   
  ------------------ ----------- ------------ ------------ ------------ ------------ ----------------------------------------- ------------- ---------------------------------------- -------- --------
  Glucose (mmol/L)     4.8±0.5     4.8± 0.5     4.6±0.5      4.8±0.8      5.0±0.6                    4.9± 1.70                    4.9±0.5                    4.7±0.6                    0.89     0.63
  HOMA-IR             1.53±1.01   1.36±0.66    0.76±0.59    1.28±1.46    1.54±1.36                   1.23±0.99                   1.43±1.01                  0.94±0.35                   0.50     0.34
  CK (µmol/L)         90.1±26.9   113.8±29.8   103.3±31.7   120.3±38.6   114.8±50.1                 180.3±120.5                 146.0±153.3                187.7±181.7                 0.0001    0.78
  Bili (µmol/L)        9.3±2.9     10.6±2.3     7.5±2.2      7.5±1.5      10.5±3.9                   11.6±6.0                     7.5±3.0                    7.8±2.4                    0.17     0.02
  GGT (µmol/L)        26.4±7.9     25.5±4.9    27.3±17.0    26.6±12.4    30.5±22.5                   27.8±22.3                   21.2±12.8                   22.6±5.9                   0.90     0.90
  Crn (µmol/L)          87±10        86±6        71±10        70±14        90±19      114±25[\*](#nt110){ref-type="table-fn"}      71±11      80±17[\*](#nt110){ref-type="table-fn"}   0.0001   0.0001
  LDL (mmol/L)        3.03±0.56   3.33±0.75    3.27±1.08    3.46±1.19    3.14±0.45                   3.33±0.54                   3.20±0.96                  3.54±0.85                  0.002     0.83
  HDL (mmol/L)        1.57±0.32   1.63±0.39    2.07±0.45    2.22±0.59    1.32±0.28                   1.34±0.21                   1.82±0.31                  1.83±0.37                   0.09    0.0001
  Chol (mmol/L)       5.35±0.57   5.68±0.85    5.96±1.16    6.32±1.38    5.37±0.51                   5.54±0.72                   5.68±1.09                  6.13±1.00                  0.0007    0.23
  LDL/HDL (mmol/L)    2.02±0.59   2.19±0.81    1.65±0.68    1.62±0.62    2.47±0.62                   2.54±0.59                   1.84±0.79                  2.02±0.72                  0.097    0.018
  Leptin (ng/mL)      4.54±1.87   4.84±2.26    16.0±10.26   15.33±9.61   4.84±2.47                   4.38±3.70                  16.21±12.74                16.95±15.97                  0.97    0.0003
  CRP (mg/L)          2.98±3.24   1.85±1.05    3.65±3.62    3.80±4.25    2.56±3.12                   3.79±4.33                   3.31±3.5                   5.12±3.47                   0.44     0.23
  Adipon. (mg/L)      9.65±4.33   10.32±3.96   17.12±7.54   16.47±6.33   7.18±4.39                   6.48±3.19                  12.89±5.84                  13.72±7.1                   0.96    0.0003
  IL-6 (pg/mL)        2.38±3.2    2.33±2.21    3.91±3.03    4.06±3.05    5.48±3.08                   7.3±4.47                    1.81±1.46                   2.04±.82                   0.10     0.61

Values are means±standard deviation. HOMA-IR = homeostasis model assessment of insulin resistance; CK = creatine kinase; billi = bilirubin; GGT = gamma glutamyl transferase; LDL = low density lipoprotein; HDL = high density lipoprotein; Chol = total cholesterol; CRP = C-reactive protein; Adipon. = adiponectin; IL-6 = interleukin -6.

indicates a significant interaction between training and supplement (see text).

Urine Analyses {#s3f}
--------------

Women had higher 8-OH-2dG/creatinine and Cr/Crn ratios and lower 24 h creatinine compared to men ([Table 6](#pone-0000991-t006){ref-type="table"}). Urinary creatine, creatinine and Cr/Crn ratios were all higher following training only in the Cr+CLA supplemented group ([Table 6](#pone-0000991-t006){ref-type="table"}). Neither resistance training, nor the CrM+CLA supplement, influenced the measured plasma creatinine clearance. The 8-OH2-dG/creatinine ratio was lower for both groups following training ([Table 6](#pone-0000991-t006){ref-type="table"}). In contrast, the 8-isoP/creatinine ratio was higher following training only for the females in the CrM+CLA group ([Table 6](#pone-0000991-t006){ref-type="table"}). There were no effects of sex, exercise training or CrM+CLA supplementation on urinary N-telopeptide excretion ([Table 6](#pone-0000991-t006){ref-type="table"}).

10.1371/journal.pone.0000991.t006

###### Urine Analysis.

![](pone.0000991.t006){#pone-0000991-t006-6}

                               Placebo       Supplement                                                                                                                                                                      
  ------------------------- -------------- -------------- ------------- ------------- -------------- ------------------------------------------------ ------------- ----------------------------------------------- -------- --------
  Cr (mg/24 hr)               43.7±51.8      31.9±39.7      150±128.1    181.3±145.5     66±62.6      1851.1± 933.5[\*](#nt112){ref-type="table-fn"}   171.4±153.9   2393.7± 1656[\*](#nt112){ref-type="table-fn"}   0.0002    0.11
  Crn (mg/24 hr)             1265.6±284.0   1293.2±217.0   978.3±258.2   979.0±123.8   1432.1±363.2   1808.0±544.0[\*](#nt112){ref-type="table-fn"}    935.9±158.8   1034.1± 31.6[\*](#nt112){ref-type="table-fn"}   0.002    0.0001
  Crn Cl. (mL/sec)            1.51±0.36      1.54±0.32      1.44±0.44     1.49±0.36     1.72±0.65                       1.70±0.71                       1.39±0.33                      1.40±0.45                      0.73     0.21
  Cr/Crn ratio                0.04±0.05      0.02±0.03      0.16±0.14     0.19±0.17     0.05±0.06       1.11±1.24[\*](#nt112){ref-type="table-fn"}      0.18±0.16     2.24±1.52[\*](#nt112){ref-type="table-fn"}     0.0003   0.009
  8-OH/Crn (ng/g Crn)         8329±3032      7394±1921     11622±4379    10713±3190     7245±2703                       6130±1260                       7942±3071                      7088±2582                      0.01     0.03
  8-iso/Crn (pg/mg Crn)        2.9±1.3        3.8±1.0        3.8±1.3       4.1±2.1       2.5±2.2                         2.3±1.4                         5.2±2.3        9.9±6.2[‡](#nt113){ref-type="table-fn"}       0.03    0.005
  *N*-telo (BCE/mmol Crn)    380.6±335.7    378.1±275.6    354.7±231.3   235.9±146.5    510±353.3                      712.4±714.4                     257.7±79.7                     272.1±154.2                     0.67     0.09

Values are means±standard deviation. 8-OH = 8-hydroxy-2-deoxyguanosine; 8-Iso. = 8-isoprostane per 24 hour urine; Cr = Creatine; Crn = creatinine; Cl. = Clearance; *N*-telo = *N*-telopeptides; BCE = bone collagen equivalent.

indicates a significant interaction between training and supplement (see text).

indicates a significant interaction between training, supplement and gender (see text).

Side Effects {#s3g}
------------

Subjects tolerated the supplementation protocol well, with only one report of gastrointestinal distress (stomach cramps) on CrM+CLA but this did not lead to discontinuance of the study. Furthermore, there were no reports of muscular cramping or any other subjective symptoms during the study. Subjects variably reported delayed onset muscle soreness yet none developed any musculoskeletal injuries that required them to discontinue the study. Two individuals complained of anterior knee pain during the knee extension exercises that required a slower increase in the intensity of the training sessions. No individual dropped out due to musculoskeletal injuries.

Discussion {#s4}
==========

We found that six months of twice weekly, supervised, resistance exercise training robustly improved muscle strength and functional capacity in community dwelling older adults. Significant improvements in body composition (increased FFM and lower fat mass) were seen following resistance exercise training only for the CrM+CLA intervention group. There were several measurements of strength that were higher after training on the CrM+CLA arm of the study, particularly muscular endurance. Other than a reduction in a marker of DNA oxidative stress (8-OH-2-dG) there were no other blood or urine markers that showed changes that would be consistent with a reduction in risk for the metabolic syndrome following resistance exercise training. No adverse affects were noted clinically or serologically, and markers of inflammation (CRP and IL-6), adipocytokines (leptin and adiponectin), and glucose homeostasis (fasting glucose and HOMA-IR index) showed no effect from training or supplementation. Total cholesterol and LDL increased following training for all groups, but the LDL/HDL ratio did not change.

Previous findings of an augmented increase in FFM following resistance exercise training with CrM administration in older adults [@pone.0000991-Chrusch1], [@pone.0000991-Brose1], were confirmed in the current study. We have also previously reported that older adults show a significant increase in total muscle creatine following four months of CrM supplementation at the same dose as used in the current study [@pone.0000991-Brose1]. An increase in satellite cell number occurs in older adults in response to resistance exercise training [@pone.0000991-Mackey1], [@pone.0000991-Dreyer1], and CrM has recently been shown to enhance satellite cell activation during resistance exercise training in younger men [@pone.0000991-Olsen1]. Together, the aforementioned data suggest that CrM may enhance the resistance exercise induced activation of satellite cells and contribute to the increase in FFM seen in the current study. It is not possible to determine what proportion of the increase in FFM was due to the CrM and what may have been due to the CLA component of the supplement. It is likely that much of the increase in FFM was due to CrM given that the potentiation of the FFM gains seen in the current study were quantitatively similar to those previously reported by our group [@pone.0000991-Brose1], and others [@pone.0000991-Chrusch1], using CrM only. Furthermore, CLA supplementation alone does not appear to enhance FFM gains in young men completing a resistance exercise program [@pone.0000991-Kreider2]. The molecular mechanism(s) behind the observed enhancement of the FFM with CrM were not evaluated in the current study and may have included an increase in satellite cell recruitment [@pone.0000991-Olsen1], [@pone.0000991-Dangott1], lower protein breakdown and oxidation [@pone.0000991-Parise1], or increased myofibrillar protein accretion [@pone.0000991-Willoughby1]. Given that the progression of the exercise program was set as a parameter for each participant, that we recorded every repetition and weight lifted during the entire six months of training, and that the final 1 RM values were the same for all groups (aside from slightly greater increases in 2 of 10 exercises for the women on supplement), the total "volume" of training over the six months was virtually identical between supplemented and non-supplemented groups (especially for men). Consequently, some of the improvements in mass and muscular endurance must have been due to molecular or physiological alterations induced by the supplement *per se* and not due to a higher total volume of exercise over the six months.

In addition to a greater increase in FFM after training with the CrM+CLA supplement, we found that several measurements of strength increased to a greater degree in the supplemented groups. In a previous study we found that isometric knee extension strength increased for men and women, and dorsiflexion strength increased only for men following four months of resistance exercise training (3 x/wk) [@pone.0000991-Brose1]. In spite of men showing higher strength values for every outcome measurement in the current study, most measurements of strength improved similarly for men and women. Knee extension strength was the only strength outcome that showed a sex difference with greater increases for women on CrM+CLA after training compared to all other groups. Since we found that those with the lowest initial strength showed the greatest percentage improvements in strength (r = −0.61), it may be that this latter finding was reflective of the lower initial strength in the women randomized to CrM+CLA and not a true effect of the supplement *per se*. Nevertheless, this latter finding is of significant clinical relevance because older adults with very low levels of strength are at the greatest risk of falling [@pone.0000991-Luukinen1], [@pone.0000991-Sturnieks1], and therefore, it is this group that would stand to gain the most from a resistance exercise training program.

A novel finding in the current study was the robust reduction in the fat mass seen after resistance training in the CrM+CLA group. We feel that this effect was primarily due to the CLA component for a number of reasons. Firstly, almost every study looking at the effects of CrM alone during resistance exercise training did not find any effect on fat mass [@pone.0000991-Volek1], [@pone.0000991-Chrusch1], [@pone.0000991-Brose1]. Secondly, studies in overweight humans have found a lower fat mass after CLA supplementation at about the same dose as used in the current study [@pone.0000991-Gaullier1]--[@pone.0000991-Gaullier2], [@pone.0000991-Whigham1]. Finally, there is strong biological rationale for a reduction in body fat secondary to CLA supplementation. CLA has consistently been shown to lower body fat in animals, likely by increasing PPARα, and SREBP1 in adipocytes and inducing transcription of components of β-oxidation [@pone.0000991-Wendel1], [@pone.0000991-Takahashi1], [@pone.0000991-Wang1]. CLA has also recently demonstrated an ability to normalize impaired glucose tolerance and improve hyperinsulinemia in a pre-diabetic animal model. It is not clear what the distribution of body fat was in the current study because CT or MRI scanning was not used to quantify intra-abdominal fat stores. Given that abdominal obesity and intra abdominal fat are greater metabolic risk factors for the metabolic syndrome complications [@pone.0000991-Onat1], [@pone.0000991-Busetto1], it will be important in future studies to evaluate these variables in response to training and CLA.

A large number of studies have looked at the beneficial effects of endurance exercise training on serum markers of metabolic risk including; inflammation (CRP, IL-6, TNF), dysglycemia (HOMA-IR, euglycemic clamps, fasting glucose, hemoglobin A1C), oxidative stress (8-isoP, oxidized LDL), or adipocytokines (leptin, adiponectin) [@pone.0000991-Fatouros1], [@pone.0000991-Marcell1]--[@pone.0000991-Bluher1]. Fewer studies have examined the potential for resistance exercise to favorably alter serum variables associated with higher risk of metabolic disease complications [@pone.0000991-Fatouros1], [@pone.0000991-Dunstan1], [@pone.0000991-Castaneda1]. Two studies have found that resistance exercise reduced hemoglobin A1C in older adults with type 2 diabetes [@pone.0000991-Dunstan1], [@pone.0000991-Castaneda1]. We did not find any evidence of a beneficial influence of training or CrM+CLA on HOMA-IR or fasting blood glucose in the current study. However, this could be due to the fact that none of our older adults had type 2 diabetes, and therefore, the potential for improvement was less. There has been some concern that CLA administration (either the c9, t11 or t10, c12 isomer) could lead to an increase in markers of oxidative stress and that this was responsible for an increase in insulin resistance [@pone.0000991-Riserus1], [@pone.0000991-Riserus2]. In contrast, CLA supplements containing combinations of the two major isomers taken together did not show the same negative effects on oxidative stress or systemic inflammation [@pone.0000991-Riserus1]. We found that the women who took the CrM+CLA supplement had higher concentrations of 8-isoprostanes as compared with all other groups. Given that neither this group nor the others showed any evidence of oxidative stress using the DNA marker, renders the biological significance unclear. Our data suggests that a combination of CLA isomers taken during a resistance exercise training program does not negatively influence markers of inflammation (CRP, IL-6) or dysglycemia (HOMA-IR, fasting glucose) or markers of DNA oxidative damage (8-OH-2dG).

The results of the current study confirmed our earlier finding that resistance exercise training was associated with a reduction in a marker of DNA oxidative stress (8-OH-2dG) [@pone.0000991-Parise2]. Our previous work using a similar training stimulus indicated that this effect was due to a training induced induction of the anti-oxidant enzymes, catalase and Cu/Zn superoxide dismutase [@pone.0000991-Parise3]. In contrast, there was no beneficial effect consequent to the training program with respect to oxidative stress measured using the 8-isoprostanes, and the women on CrM+CLA showed an increase in 8-isoprostanes after training. One study found that acute resistance exercise did not alter 8-isoprostanes in blood [@pone.0000991-McAnulty1], and another found no difference in 8-isoprostanes in trained athletes compared to sedentary controls [@pone.0000991-Watson1]. Our data is in general agreement with the latter two studies in that three of our groups showed no significant influence of training on 24 h 8-isoprostane excretion. The biological significance of the increase in 8-isoprostanes for women on CrM+CLA is unclear as is the discrepancy between the 8-OH2dG and the 8-isoprostane results. Our data showing that resistance exercise training leads to an increase in anti-oxidant enzyme activity in older adults renders the 8-OH-2dG results more biologically plausible.

Several studies have found that endurance exercise can favorably improve blood lipid profiles in a direction associated with a lower risk of cardiovascular disease risk (↓ LDL, ↑ HDL) [@pone.0000991-Halbert1], while others have found that up to six months of endurance training had no effect on LDL or total cholesterol values [@pone.0000991-Wilund1], [@pone.0000991-Banz1]. The evidence for resistance exercise to improve blood lipid profiles is less consistent or robust [@pone.0000991-Boyden1]. Other factors such as hormonal status in women can influence the response of LDL to an endurance exercise stimulus with increases only seen for women taking hormone replacement [@pone.0000991-Green1]. Another group found that genotype influenced the HDL response to 6 months of endurance exercise training where increases were only seen for a specific genotype in the cholesteryl ester transfer protein allele [@pone.0000991-Wilund1]. In the current study there were significant increases seen for both LDL and total cholesterol in both sexes and in both groups after six months of training, yet the ratio of LDL/HDL was not altered. Given that the trial was six months in duration and we did not have a non-exercised control group, it is possible that this minor alteration represented a normal aging phenomenon. Whether or not longer term supplementation with CLA [@pone.0000991-Gaullier1], and/or a longer duration of training would have beneficial effects on lipid profiles is unclear.

Resistance training has been shown to have variable and inconsistent effect upon bone turnover and bone density. Some have shown improvements in markers of bone turnover within 16 weeks of high intensity weight training [@pone.0000991-Sartorio1], while others have observed improvements in bone mineral density and osteocalcin after 6 months of high intensity weight training [@pone.0000991-Vincent1], in older adults. In contrast, others have reported no changes in markers of bone turnover following 12 weeks of resistance training in older women [@pone.0000991-Mullins1]. The lack of consistency in the response of bone to resistance training likely results from a number of different factors including differences in training intensity and duration and subject population factors such as aging. Given that the osteogenic response to weight training appears to be blunted in older adults [@pone.0000991-Kohrt1], and that changes in bone mineral density in response to any intervention take from 6 months to a year to detect [@pone.0000991-Vincent1], it is possible that a higher intensity or a longer duration may have favorably influenced bone mass and markers in the current study. Creatine monohydrate has been shown to stimulate metabolic activity, differentiation and mineralization in osteoblast-like cell cultures [@pone.0000991-Gerber1]. Two groups have found lower *N*-telopeptide excretion (a marker of bone catabolism) in boys and young men with muscular dystrophy following CrM supplementation [@pone.0000991-Tarnopolsky3], [@pone.0000991-Louis1]. In contrast, we did not find any effect of four months of resistance exercise training with or without CrM supplementation on bone mineral density or osteocalcin in older men and women [@pone.0000991-Brose1]. In the current study we did not find any beneficial effects of either the CrM+CLA supplement or resistance training on markers of bone turnover or bone density measurements.

No participants experienced side effects from the training or the supplementation that led to discontinuance of the study. These findings concur with other studies using progressive weight training in older adults [@pone.0000991-Fiatarone1], [@pone.0000991-Skelton1], [@pone.0000991-Chrusch1], [@pone.0000991-Chilibeck1], and those with obesity and type 2 diabetes [@pone.0000991-Fatouros1], [@pone.0000991-Dunstan1], [@pone.0000991-Castaneda1]. We did start with a fairly modest initial intensity of 50% of the 1 RM, which we have found to be safe in the training of older adults in the past [@pone.0000991-Brose1]. There was a slight increase in serum CK activity with resistance training; however, this was not associated with any pigmenturia, muscle cramps and in no case was the CK elevation greater than 400 U/L (N\<220 U/L), and there were no differential increased in CK activity with the CrM+CLA supplement. Given that creatine is converted non-enzymatically to creatinine, we did find the expected and previously reported [@pone.0000991-Brose1], increase in serum creatinine for the groups taking the supplement containing CrM. As with our previous study [@pone.0000991-Brose1], we did not find any influence on measured creatinine clearance, which we took to indicate that there were no negative effects on renal function. Furthermore, others have not found any evidence of renal dysfunction with short and long-term CrM administration [@pone.0000991-Brose1], [@pone.0000991-Mihic1]--[@pone.0000991-Poortmans2].

In conclusion, we have confirmed the beneficial effects of resistance exercise training on increasing FFM, strength, and function in older adults and have added novel data showing that a combination of CrM+CLA lead to greater increases in FFM and losses of fat mass. Furthermore, those on the supplement showed greater muscular endurance and no evidence of clinical or serological side effects. Whether such changes are maintained in the longer term is unclear at this point.
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